Venus Remedies Limited (BSE: 526953)
Health Care · Pharmaceuticals · IN
Rs1,630.75
-8.61% today · +253.7% 1Y
Venus Remedies Limited (BSE: 526953) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $225.23M.
Over the last twelve months the share price has gained 253.7%, trading between 432.00 and 2.04K.
Tweenvest scores Venus Remedies Limited across four factors: quality 74/100, value 26/100, growth 80/100, dividend 45/100. Its strongest factor is growth.
526953 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $225.23M
- Revenue (TTM)
- $85.80M
- P/E
- 18.77
- EPS
- 86.89
- Dividend yield
- 0.61%
- Beta (5Y)
- 0.33
- 52-week high
- Rs2,043.15
- 52-week low
- Rs432.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.37M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sakar Healthcare LimitedNSEI: SAKAR | $232.54M | Rs1,011.50 | -5.91% |
| Savior Lifetec CorporationTPEX: 4167 | $228.12M | NT$22.00 | +12.53% |
| Syncom Formulations (India) LimitedBSE: 524470 | $225.92M | Rs23.26 | -2.96% |
| Sai Parenteral's LimitedNSEI: SAIPARENT | $225.46M | Rs493.90 | -5.68% |
| Imexpharm CorporationHOSE: IMP | $220.14M | ₫37,000.00 | +1.09% |
| Indoco Remedies LimitedNSEI: INDOCO | $220.03M | Rs230.70 | -8.36% |
| JW Holdings CorporationKOSE: A096760 | $211.27M | ₩4,105.00 | -4.20% |
| Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)CASE: RMDA | $210.00M | EGP5.41 | -0.73% |
Figures last refreshed Oct 11, 2026.